ELITE PHARMACEUTICALS INC /NV/ Quarterly Share-based Payment Arrangement, Expense in USD from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q4 2013 to Q3 2024.
  • Elite Pharmaceuticals Inc /Nv/ Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $52.3K, a 22.3% increase year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $207K, a 141% increase year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ annual Share-based Payment Arrangement, Expense for 2023 was $160K, a 307% increase from 2022.
  • Elite Pharmaceuticals Inc /Nv/ annual Share-based Payment Arrangement, Expense for 2022 was $39.3K, a 174% increase from 2021.
  • Elite Pharmaceuticals Inc /Nv/ annual Share-based Payment Arrangement, Expense for 2021 was $14.4K, a 8.89% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $207K $52.3K +$9.55K +22.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $197K $52.3K +$37.3K +249% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $160K $52.3K +$37.3K +249% Jan 1, 2024 Mar 31, 2024 10-K 2024-07-01
Q4 2023 $123K $49.8K +$36.8K +282% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 $85.8K $42.8K +$36.8K +616% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $49K $15K +$9.68K +182% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $39.3K $15K +$11.3K +301% Jan 1, 2023 Mar 31, 2023 10-K 2024-07-01
Q4 2022 $28.1K $13K +$9.4K +259% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 $18.7K $5.97K +$1.8K +43% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $16.9K $5.32K +$2.51K +89.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $14.4K $3.74K -$184 -4.69% Jan 1, 2022 Mar 31, 2022 10-K 2023-06-29
Q4 2021 $14.5K $3.63K +$1.98K +120% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 $12.6K $4.18K +$2.09K +99.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $10.5K $2.81K -$2.71K -49.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $13.2K $3.92K -$4.66K -54.3% Jan 1, 2021 Mar 31, 2021 10-K 2022-06-29
Q4 2020 $17.8K $1.65K -$10.2K -86% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $28K $2.09K -$13.4K -86.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $41.4K $5.52K -$20.7K -78.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $62.1K $8.58K -$18.1K -67.9% Jan 1, 2020 Mar 31, 2020 10-K 2021-06-14
Q4 2019 $80.2K $11.8K -$24.7K -67.7% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 $105K $15.5K -$21K -57.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $126K $26.2K -$10.4K -28.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $136K $26.7K -$9.31K -25.8% Jan 1, 2019 Mar 31, 2019 10-K 2020-06-30
Q4 2018 $146K $36.5K -$1.41K -3.73% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q3 2018 $147K $36.5K -$36.9K -50.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $184K $36.5K -$60.8K -62.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $245K $36K -$63K -63.6% Jan 1, 2018 Mar 31, 2018 10-K 2019-06-21
Q4 2017 $308K $38K -$46.8K -55.2% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-11
Q3 2017 $355K $73.4K -$11.4K -13.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $366K $97.4K +$7.98K +8.92% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $358K $99K +$12.1K +14% Jan 1, 2017 Mar 31, 2017 10-K 2018-06-14
Q4 2016 $346K $84.8K +$9.76K +13% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 $336K $84.8K +$3.79K +4.68% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $332K $89.4K -$1.1K -1.21% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $333K $86.9K -$6.53K -6.99% Jan 1, 2016 Mar 31, 2016 10-K 2018-06-14
Q4 2015 $340K $75K -$14.5K -16.2% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 $354K $81K +$27.5K +51.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $327K $90.5K +$66.8K +282% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $260K $93.4K Jan 1, 2015 Mar 31, 2015 10-K 2017-06-14
Q4 2014 $89.5K +$65.8K +278% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 $53.5K Jul 1, 2014 Sep 30, 2014 10-Q/A 2015-12-30
Q2 2014 $23.7K Apr 1, 2014 Jun 30, 2014 10-Q/A 2015-12-30
Q4 2013 $23.7K Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.